UPDATE 1-French biotech firm Cellectis jumps on takeover hopes

May 29 (Reuters) - Shares in French cancer drugmaker Cellectis hit an all-time high on Friday on hopes it would be the latest in a string of bid targets in the healthcare sector, after reported interest from companies including Pfizer .